CurePSP announced that its network of Centers of Care has grown to 38 institutions with the addition of the University of Colorado Anschutz Medical Campus, University of Texas Health Science Center at ...
On September 22, GemVax & KAEL announced that it has applied for the U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for ...
Milton Keynes Citizen on MSN
Rare disease charity announces new CEO
The PSP Association (PSPA), the UK’s leading charity supporting everyone affected by Progressive Supranuclear Palsy (PSP) and ...
On September 23, GemVax & KAEL announced that it has completed all dosing for the Phase 2 extension clinical trial of 'GV1001', its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback